Literature DB >> 28089265

Gender differences in Parkinson's disease depression.

Andrew J Perrin1, Ekaterina Nosova2, Kim Co2, Adam Book3, Oscar Iu2, Vanessa Silva3, Christina Thompson2, Martin J McKeown4, A Jon Stoessl4, Matthew J Farrer2, Silke Appel-Cresswell5.   

Abstract

INTRODUCTION: 30-40% of patients with Parkinson's disease (PD) experience depression during their illness; identifying subtypes of depression and groups at risk remains a challenge in routine clinical care. One avenue that remains underexplored is the gender-specific profiles manifested in PD depression. We sought to explore this in a large sample of clinical PD patients.
METHODS: 307 patient records at a tertiary referral centre were reviewed for clinical and demographic factors. We used recursive partitioning to determine which items on the Beck Depression Inventory (BDI) were most useful in differentiating patients who scored in the depressed range (≥14) from those who scored in the non-depressed range (≤13). We also used recursive partitioning to identify those BDI items that were most effective in differentiating depressed from non-depressed patients in both genders.
RESULTS: We were able to identify a subset of items on the BDI that were most useful in partitioning depressed from non-depressed in the entire cohort. Partitioning of men and women with PD depression relied on different key BDI items, melancholy featuring prominently in women, while the more classical factors associated with depression in PD (apathy and loss of libido) featured more prominently in men.
CONCLUSION: Unique factors not previously identified as core features of depression in PD were found most useful in partitioning depressed women from non-depressed women. This raises the possibility that a female-specific depressive profile has been under-appreciated in past work. Additional studies are required to discern how this may impact future research, diagnosis and treatment.
Copyright © 2017 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Beck depression inventory; Depression; Gender; Parkinson's disease; Recursive partitioning

Mesh:

Year:  2016        PMID: 28089265     DOI: 10.1016/j.parkreldis.2016.12.026

Source DB:  PubMed          Journal:  Parkinsonism Relat Disord        ISSN: 1353-8020            Impact factor:   4.891


  6 in total

1.  Apathy Mediates Cognitive Difficulties in Geriatric Depression.

Authors:  Cynthia M Funes; Helen Lavretsky; Linda Ercoli; Natalie St Cyr; Prabha Siddarth
Journal:  Am J Geriatr Psychiatry       Date:  2017-06-16       Impact factor: 4.105

Review 2.  Subtyping of Parkinson's Disease - Where Are We Up To?

Authors:  Elizabeth Qian; Yue Huang
Journal:  Aging Dis       Date:  2019-10-01       Impact factor: 6.745

3.  The Effects of Safinamide Adjunct Therapy on Depression and Apathy in Patients With Parkinson's Disease: Post-hoc Analysis of a Japanese Phase 2/3 Study.

Authors:  Nobutaka Hattori; Yuki Kogo; Michinori Koebis; Takayuki Ishida; Ippei Suzuki; Yoshio Tsuboi; Masahiro Nomoto
Journal:  Front Neurol       Date:  2022-02-07       Impact factor: 4.003

4.  Sex Differences in Parkinson's Disease: From Bench to Bedside.

Authors:  Maria Claudia Russillo; Valentina Andreozzi; Roberto Erro; Marina Picillo; Marianna Amboni; Sofia Cuoco; Paolo Barone; Maria Teresa Pellecchia
Journal:  Brain Sci       Date:  2022-07-13

5.  Sex differences in Parkinson's Disease: An emerging health question.

Authors:  Luiz Philipe de Souza Ferreira; Rafael André da Silva; Matheus Marques Mesquita da Costa; Vinicius Moraes de Paiva Roda; Santiago Vizcaino; Nilma R L L Janisset; Renata Ramos Vieira; José Marcos Sanches; José Maria Soares Junior; Manuel de Jesus Simões
Journal:  Clinics (Sao Paulo)       Date:  2022-10-01       Impact factor: 2.898

6.  Non-motor impairments affect walking kinematics in Parkinson disease patients: A cross-sectional study.

Authors:  Sara Liguori; Antimo Moretti; Angela Palomba; Marco Paoletta; Francesca Gimigliano; Rosa De Micco; Mattia Siciliano; Alessandro Tessitore; Giovanni Iolascon
Journal:  NeuroRehabilitation       Date:  2021       Impact factor: 2.138

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.